Announcement on Voluntary Disclosure of Positive Top-line Results from the International Multicenter Phase III Clinical Trial of Shuvozhe Monotherapy as First-line Treatment for EGFR exon20ins Non-small Cell Lung Cancer
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment